EYES News and Press, Second Sight Medical Products Inc. From 04/14/22

Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight”), a recognized global leader in neuromodulation devices for blindness, today announced that an interview with Adam Mendelsohn, Ph.D., Co-Founder and CEO of Nano Precision Medical, Inc. (“NPM”)...

Second Sight has a negative enterprise value at the moment as it has about $69 million in cash. In my view, short-selling the shares of a company with a negative enterprise value could be dangerous and bears could be better off closing their positions. However, I’m not bull...

NEW YORK, NY / ACCESSWIRE / February 16, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Spirit Airlines, Inc. (NYSE:SAVE...

Gainers: Haemonetics (NYSE:HAE) +13%. Second Sight Medical Products (NASDAQ:EYES) +8%. Catalyst Pharmaceuticals (NASDAQ:CPRX) +6%. Quotient (NASDAQ:QTNT) +5%. Ocuphire Pharma (NASDAQ:OCUP) +3%. Losers: Pulse Biosciences (NASDAQ:PLSE) -36%. Karyopharm Th...

Velodyne Lidar (NASDAQ:VLDR) +40% surges after Amazon pact with sensor maker. uCloudlink (NASDAQ:UCL) +39%. Society Pass (NASDAQ:SOPA) +34%. Splash Beverage (NYSE:SBEV) +8% signs distribution agreement with Anheuser-Busch Distributor Heimark distributing for TapouT in Southern ...

Second Sight Medical Products (NASDAQ:EYES) will acquire Nano Precision Medical (NPM) and merge it with a wholly-owned subsidiary in an all-stock transaction. EYES will issue ~134M shares to acquire NPM. Second Sight shareholders will own ~23% of the combined firm. NPM will be the surviving c...

Nano Precision Medical’s lead program (NPM-119) is a tiny subdermal implant of a GLP-1 receptor agonist to treat patients with Type 2 diabetes Second Sight will issue 134M shares to acquire full ownership of Nano Precision Medical. Second Sight shareholders will own ~23% of...

Today there is a massive $13.6 billion neurostimulation devices market developing for the ongoing study of the vast arrays of the brain’s neural connections. (1) The diagnostic electrode technology currently used to detect neurological disorders is the same that was developed way back ...

Gainers: InMed Pharmaceuticals INM +40%. EyePoint Pharmaceuticals EYPT +27%. Where Food Comes From (NASDAQ:WFCF) +20%. Camber Energy (NYSE:CEI) +19%. Zhangmen Education (NYSE:ZME) +16%. Dogness (NASDAQ:DOGZ) +16%. Tattooed Chef TTCF +13%. On Holding ONON +13%. Jowell Globa...

The stock market's rebound to new highs is masking weakness under the surface. The POWR Ratings can help you identify weak stocks as the list is updated daily with upgrades and downgrades. Let’s shift our attention to a couple of the latest POWR Ratings downgrades. Take a look at Alfi ...